MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$19,864,902
Unit: Dollar

Income Statement
2025-12-31
Research and development
11,708,906
General and administrative
8,491,125
Total operating expenses
20,200,031
Loss from operations
-20,200,031
Gain on remeasurement of warrant liabilities
89,010
Interest expense
13,402
Interest income
311,370
Other expense, net
-32,960
Total other income, net
354,018
Loss before provision for income taxes
-19,846,013
Provision for income taxes
18,889
Net loss
-19,864,902
Basic EPS
-5.48
Basic Average Shares
3,627,890
Unit: Dollar.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$19,864,902 Interest income$311,370 Gain onremeasurement of warrant...$89,010 Loss beforeprovision for income taxes-$19,846,013 Provision for income taxes$18,889 Total other income,net$354,018 Other expense, net-$32,960 Interest expense$13,402 Loss from operations-$20,200,031 Total operatingexpenses$20,200,031 Research and development$11,708,906 General andadministrative$8,491,125

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)

REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)